Not Yet Recruiting PHASE3 INTERVENTIONAL 2-arm
NCT07220902
Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure (LEVMag)
Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure: A Randomized Controlled Trial LEVMag Trial
Sponsor: Nebraska Methodist Health System
Conditions
Eclampsia Preeclampsia Severe Preeclampsia
Interventions
Levetiracetam magnesium sulfate
Updated 1 time since 2025 Last updated: Oct 22, 2025 Started: Jan 1, 2026 Primary completion: Dec 31, 2033 Completion: Jul 31, 2034
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE3 clinical study on Eclampsia Preeclampsia and Severe Preeclampsia, this trial is actively recruiting participants. The trial is conducted by Nebraska Methodist Health System and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Nebraska Methodist Health System
Data source: Nebraska Methodist Health System
For direct contact, visit the study record on ClinicalTrials.gov .